Orchard Therapeutics plc (ORTX)

Orchard Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	757	47	166	422	1,143	1,307
Market Cap Growth	177.80%	-71.63%	-60.77%	-63.04%	-12.59%	-
Enterprise Value	679	-39	5	288	863	971
PE Ratio	-	-0.31	-1.15	-2.78	-6.99	-5.67
PS Ratio	34.65	2.08	98.90	162.73	454.66	629.62
PB Ratio	9.43	0.48	0.79	2.37	3.82	4.20
P/FCF Ratio	-2.03	-0.63	-1.30	-3.08	-6.70	-12.87
P/OCF Ratio	-1.88	-0.62	-1.32	-3.34	-6.88	-13.40
EV/Sales Ratio	31.10	-1.71	3.01	111.17	343.60	467.84
EV/EBITDA Ratio	-1.47	0.26	-0.04	-1.94	-5.32	-4.25
EV/EBIT Ratio	-1.42	0.26	-0.04	-1.92	-5.26	-4.23
EV/FCF Ratio	-1.13	0.52	-0.04	-2.10	-5.06	-9.56
Debt / Equity Ratio	0.60	0.59	0.28	0.33	0.15	-
Debt / EBITDA Ratio	-0.72	-0.39	-0.43	-0.39	-0.28	-
Debt / FCF Ratio	-0.55	-0.78	-0.47	-0.42	-0.27	-
Quick Ratio	2.67	2.51	5.18	3.74	5.84	7.05
Current Ratio	3.12	2.78	6.43	4.34	6.26	7.42
Asset Turnover	0.10	0.09	0.01	0.01	0.01	0.01
Interest Coverage	-18.24	-48.70	-56.57	-64.60	-106.71	-
Return on Equity (ROE)	-74.90%	-110.80%	-57.20%	-69.30%	-53.50%	-115.90%
Return on Assets (ROA)	-33.50%	-60.00%	-40.40%	-48.70%	-42.70%	-99.50%
Return on Capital (ROIC)	-79.65%	-81.28%	-52.12%	-66.35%	-50.09%	-75.49%
Earnings Yield	-9.64%	-320.54%	-87.28%	-35.99%	-14.30%	-17.63%
FCF Yield	-11.42%	-158.58%	-76.80%	-32.46%	-14.92%	-7.77%
Buyback Yield / Dilution	-78.24%	-3.24%	-24.65%	-6.66%	-313.31%	-154.25%
Total Shareholder Return	-78.24%	-3.24%	-24.65%	-6.66%	-313.31%	-154.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).